Discover how music therapy is revolutionizing stroke rehabilitation and improving mobility
- Music therapy can help with anxiety, depression, chronic pain, developmental disorders, autism, and dementia
- MedRhythms Inc. uses music therapy to treat stroke patients with reduced mobility
- InTandem, a product by MedRhythms, helps restore a stronger walking gait in stroke patients
- InTandem has been shown to produce immediate and long-term improvements in gait and walking speed
- Almost four million people in the U.S. have a walking deficit related to a stroke
- MedRhythms is developing products for multiple sclerosis and Parkinson’s disease
- Music therapy has been used since the first and second world wars to improve mood and functioning
- InTandem uses sensors and proprietary software to synchronize motor movement with music
- MedRhythms has a partnership with Universal Music Group to use its catalog of artists and music
- MedRhythms has raised about $57 million in financing since launching in 2015
As a board-certified music therapist, Brian Harris knows firsthand the power of music to treat patients and transform care. In building the music-therapy program at Spaulding Rehabilitation Hospital, Harris worked closely with stroke and brain-injury patients. MedRhythms Inc., a neurotherapeutics company, is now using music therapy to help stroke patients with reduced mobility. Their product, InTandem, has been shown to produce immediate and long-term improvements in gait and walking speed. With almost four million people in the U.S. having a walking deficit related to a stroke, MedRhythms is providing new hope for stroke rehabilitation. They are also developing products for multiple sclerosis and Parkinson’s disease. Music therapy has a long history of improving mood and functioning, and InTandem uses sensors and proprietary software to synchronize motor movement with music. MedRhythms has partnered with Universal Music Group to provide a wide choice of genres and artists for their therapy. With $57 million in financing, MedRhythms is on a mission to revolutionize rehabilitation and improve the lives of patients.
Factuality Level: 8
Factuality Justification: The article provides detailed information about MedRhythms Inc., its product InTandem, and the impact of music therapy on stroke patients. It includes quotes from experts and clinical studies to support the effectiveness of the product. The information is presented in a factual and informative manner without significant bias or sensationalism.
Criteria1: 3
Criteria2: 4
Criteria3: 8
Criteria4: 9
Criteria5: 9
Criteria6: 8
Criteria7: 7
Criteria8: 8
Criteria9: 8
Noise Level: 4
Noise Justification: The article provides valuable information about the use of music therapy in treating patients with neurological conditions, specifically focusing on a product called InTandem by MedRhythms Inc. It includes scientific evidence, expert opinions, and details about the technology. However, it contains some repetitive information and unnecessary details about the company’s financials and partnerships, which could be considered noise.
Financial Relevance: Yes
Financial Markets Impacted: The article does not provide specific information about financial markets or companies impacted.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article discusses the use of music therapy in treating stroke patients and the development of a medical device by MedRhythms Inc. However, it does not mention any extreme events or their impact on financial markets or companies.
Public Companies: Biogen (BIIB), Universal Music Group (UMG, UNVGY)
Private Companies: MedRhythms Inc.
Key People: Brian Harris (Chief Executive and Co-Founder of MedRhythms Inc.), Lou Awad (Physical Therapist and Rehabilitation Scientist, Founding Director of Boston University’s Neuromotor Recovery Laboratory)
Reported publicly:
www.marketwatch.com 
